Evidence map›Paper›PMID 35874634›Full record

ArticleJournal of oncology2022

Prognostic Evaluation Based on Dual-Time

Fei Wang, Chao Cheng, Shengnan Ren, Zhongyi Wu, Tao Wang, Xiaodong Yang, Changjing Zuo, Zhuangzhi Yan, Zhaobang Liu

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Prognostic Evaluation Based on Dual-TimeJournal of oncology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Fei WangInstitute of Biomedical Engineering, School of Communication and Information Engineering, Shanghai University, Shanghai 200444, China.ORCID https://orcid.org/0000-0001-7888-625X
Chao ChengDepartment of Nuclear Medicine, Changhai Hospital, Naval Medical University, Shanghai 200433, China.
Shengnan RenDepartment of Nuclear Medicine, Changhai Hospital, Naval Medical University, Shanghai 200433, China.
Zhongyi WuDepartment of Medical Imaging, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou 215163, China.
Tao WangDepartment of Nuclear Medicine, Changhai Hospital, Naval Medical University, Shanghai 200433, China.
Xiaodong YangDepartment of Medical Imaging, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou 215163, China.ORCID https://orcid.org/0000-0002-5828-307X
Changjing ZuoDepartment of Nuclear Medicine, Changhai Hospital, Naval Medical University, Shanghai 200433, China.
Zhuangzhi YanInstitute of Biomedical Engineering, School of Communication and Information Engineering, Shanghai University, Shanghai 200444, China.ORCID https://orcid.org/0000-0002-4917-463X
Zhaobang LiuDepartment of Medical Imaging, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou 215163, China.ORCID https://orcid.org/0000-0002-8412-9930
Second Military Medical University · CNChinese Academy of Sciences · CNShanghai University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Purpose: Purpose is to explore the prognostic value of radiomics features from dual-time Materials and Methods: This retrospective study included 70 LAPC patients who received early and delayed Results: The Rad-score from dual-time images contains six features, including intensity histogram, morphological, and texture features. In the validation cohort, the univariate analysis showed that the Rad-score was the independent prognostic factor ( Conclusion: The Rad-score based on dual-time

Identifiers

PMID35874634
PMCPMC9303166
OpenAlexW4285387304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.